Cite

1. Raymond SL, Stortz JA, Mira JC, Larson SD, Wynn JL, Moldawer LL. Immunological Defects in Neonatal Sepsis and Potential Therapeutic Approaches. Front Pediatr 2017;5(14);DOI:10.3389/fped.2017.00014.10.3389/fped.2017.00014529381528224121Search in Google Scholar

2. Mukhopadhyay S, Puopolo KM. Risk Assessment in Neonatal Early-Onset Sepsis. Seminars in perinatology. 2012;36(6):408-15; DOI:10.1053/j.semperi.2012.06.00210.1053/j.semperi.2012.06.002378230223177799Search in Google Scholar

3. Liu B, Chen Y.X., Yin Q, Zhao Y.Z., Li C.S. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department. Critical Care 2013, 17:R244;DOI:10.1186/cc13070.10.1186/cc13070405632224138799Search in Google Scholar

4. Ishikura H, Nishida T, Murai A, Nakamura Y, Irie Y, Tanaka J et al. New diagnostic strategy for sepsis-induced disseminated intravascular coagulation: a prospective single-center observational study. Critical Care 2014,18:R19;DOI:10.1186/cc13700.10.1186/cc13700405742424443891Search in Google Scholar

5. Spanuth E, Ebelt H, Ivandic B, Werdan K. Diagnostic and prognostic value of presepsin (soluble CD14 sub-type) in emergency patients with early sepsis using the new assay PATHFAST Presepsin. 21st International Congress of Clinical Chemistry and Laboratory Medicine, IFCC-WorldLab – EuroMedLab, Berlin, 15-19 May 2011. Poster 0333.10.1515/9783110224641.128Search in Google Scholar

6. Wu J, Hu L, Zhang G, Wu F, He T. Accuracy of Presepsin in Sepsis Diagnosis: A Systematic Review and Meta-Analysis. PLoS ONE 10(7):e0133057.DOI: 10.1371/journal.pone.0133057.10.1371/journal.pone.0133057450799126192602Search in Google Scholar

7. Faix JD. Presepsin — The new kid on the sepsis block. Clin Biochem. 2014 May;47(7-8):503-4;DOI:10.1016/j.Search in Google Scholar

8. Montaldo P, Rosso R, Santantonio A, Chello G, Giliberti P. Presepsin for the detection of early-onset sepsis in preterm newborns.. Pediatr Res. 2017 Feb;81(2):329-34;DOI:10.1038/pr.2016.217.10.1038/pr.2016.21727925621Search in Google Scholar

9. Savić D, Simović A, Marković S, Kostić G, Vuletić B, Radivojević S, Lišanin M, Igrutinović Z, Pavlović R. The Role of Presepsin Obtained from Tracheal Aspirates in the Diagnosis of Early Onset Pneumonia in Intubated Newborns. Indian J Pediatr. 2018 Apr 14;DOI:10.1007/s12098-018-2676-2. [Epub ahead of print]10.1007/s12098-018-2676-229654571Search in Google Scholar

10. Pugni L, Pietrasanta C, Milani S, Vener C, Ronchi A, Falbo M et al. Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm Neonates. PLoS One 2015;10(12):e0146020;D OI:10.1371.10.1371/journal.pone.0146020469779426720209Search in Google Scholar

11. Topcuoglu S, Arslanbuga C, Gursoy T, Aktas A, Karatekin G, Uluhan R, Ovali F. Role of presepsin in the diagnosis of late-onset neonatal sepsis in preterm infants. J Matern Fetal Neonatal Med. 2016;29(11):1834-9;DOI:10.3109/14767058.Search in Google Scholar

12. Stubljar D, Kopitar AN, Groselj-Grenc M, Suhadolc K, Fabjan T, Skvarc M. Diagnostic Accuracy of Presepsin (sCD14-ST) for Prediction of Bacterial Infection in Cerebrospinal Fluid Samples from Children with Suspected Bacterial Meningitis or Ventriculitis. J Clin Microbiol 2015;53(4):1239-44;DOI: 10.1128/JCM.03052-14.10.1128/JCM.03052-14436520625653398Search in Google Scholar

13. Sansano S, Fearns C, Ulevitch R, Zimmerli W, Land-mann R. The origin and function of soluble CD14 in experimental bacterial meningitis. J Immunol 1999;162:4762–72.10.4049/jimmunol.162.8.4762Search in Google Scholar

14. Lin B, Noring R, Steere AC, Klempner MS, Hu LT. Soluble CD14 levels in the serum, synovial fluid, and cerebrospinal fluid of patients with various stages of Lyme disease. J Infect Dis 2000;181(3):1185-8;DOI:10.1086/315357.10.1086/31535710720552Search in Google Scholar

15. Shozushima T, Takahashi G, Matsumoto N, Kojika M, Okamura Y, Endo S. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother 2011;17(6):764-9;DOI:10.1007/s10156-011-0254-x.10.1007/s10156-011-0254-x21560033Search in Google Scholar

16. Endo S, Suzuki Y, Takahashi G, Shozushima T, Ishikura H, Murai A et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother 2012;18(6):891-7;DOI:10.1007/s10156-012-0435-2.10.1007/s10156-012-0435-222692596Search in Google Scholar

17. Janota J, Stranák Z, Bĕlohlávková S, Mudra K, Simák J. Post-natal increase of procalcitonin in premature newborns is enhanced by chorioamnionitis and neonatal sepsis. Eur J Clin Invest. 2001 Nov; 31(11):978-83;DOI:org/10.1046/j.1365-2362.2001.00912.x10.1046/j.1365-2362.2001.00912.x11737240Search in Google Scholar

18. Simonsen KA, Anderson-Berry AL, Delair SF, Davies HD. Early-Onset Neonatal Sepsis. Clinical Microbiology Reviews 2014;27(1):21-47; DOI:10.1128/CMR.00031-13.10.1128/CMR.00031-13391090424396135Search in Google Scholar

19. Wellinghausen N, Kochem AJ, Disqué C, Mühl H, Ge-bert S, Winter J et al. Diagnosis of bacteremia in whole-blood samples by use of a commercial universal 16S rRNA gene-based PCR and sequence analysis. J Clin Microbiol 2009;47(9):2759-65.;DOI: 10.1128/JCM.00567-09.10.1128/JCM.00567-09273807919571030Search in Google Scholar

20. Adib M, Bakhshiani Z, Navaei F, Saheb Fosoul F, Fouladi S, Kazemzadeh H. Procalcitonin: A Reliable Marker for the Diagnosis of Neonatal Sepsis. Iranian Journal of Basic Medical Sciences. 2012;15(2):777-782.Search in Google Scholar

eISSN:
2335-075X
ISSN:
1820-8665
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, other